The average brokerage recommendation (ABR) for Strategy (MSTR) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Although the revenue and EPS for Strategy (MSTR) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Strategy (MSTR) delivered earnings and revenue surprises of -146.98% and -3.61%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Strategy faces Q2 earnings volatility as an $8.32B digital-asset loss, financing costs and dilution risks cloud its vast Bitcoin exposure.

The shift from accumulating Bitcoin to selling it in order to service the capital structure marks a genuine change in the story.

LTH hits new highs after eight straight earnings beats and rising estimates, while MSTR faces pressure from falling estimates, debt and Bitcoin sales.

IREN's contracted AI cloud growth and financing edge make it a stronger choice than Strategy's leveraged Bitcoin model and dilution risks.

Strategy's $3.225 billion reserve may ease near-term payment pressure, but heavy debt, preferred stock and Bitcoin exposure keep financial risk elevated.

According to the average brokerage recommendation (ABR), one should invest in Strategy (MSTR). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Strategy (MSTR) closed at $100.01 in the latest trading session, marking a -1.9% move from the prior day.